广东百澳药业

Guangdong Baiao Pharmaceutical is a high-tech pharmaceutical company based in Kaiping, Guangdong, China, specializing in the research, development, and manufacturing of chemical drugs and traditional Chinese medicines (TCM). Founded in 2002, the company operates GMP-certified facilities and maintains a diverse product portfolio focused on respiratory, cardiovascular, gynecological, and urological health. Its flagship products include Xiaotanli (acetylcysteine) for respiratory mucus clearance and Qianke (diltiazem) for the treatment of hypertension and angina. The company leverages the Baosheng Group Medical Research Institute for its ongoing R&D and innovation efforts in the domestic Chinese market.